Ascertain provides AI-powered case management solutions built for health systems, payers, and independent provider groups. Its core product, Ascertain Automate, uses agentic AI to automate high-volume administrative workflows—prior authorizations, eligibility checks, discharge planning, and scheduling—and to interpret unstructured data across fragmented platforms. The company also offers tech-enabled services that operate the software on clients' behalf. Ascertain plans to accelerate growth and expand access following a $10 million Series A, aiming to enable higher-quality patient care, faster care journeys, and more cost-efficient delivery. The platform has been piloted with Northwell Health's centralized transitions-of-care team, demonstrating authorization processing and clinician time savings; the article notes case managers spend up to 60% of their time on manual tasks and there are over 100,000 open US positions for such roles. Ascertain was launched by Northwell Holdings and Aegis Ventures; CEO Mark Michalski, M.D., draws on experience from Mass General Brigham, Amazon, Butterfly Network, and Hyperfine Research. As it scales, Ascertain will move into Deerfield's Cure headquarters in New York City and leverage Deerfield, Northwell, and Aegis distribution channels and data.

Total raised

$10M

Funding rounds

1

Latest round

Series A

Latest activity

Apr 2025